Prospective study of palliative hypofractionated radiotherapy (8.5 Gy x 2) for patients with symptomatic non-small-cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 58, Issue 4, 2004, Pages 1098-1105

  Cross, Chaundré K ^a,b   Berman, Stuart ^b   Buswell, Lori ^a   Johnson, Bruce ^a   Baldini, Elizabeth H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Hypofractionation; Lung cancer; Palliation

Indexed keywords

DISEASES; PATIENT MONITORING; PATIENT TREATMENT; TOXICITY; TUMORS;

NON-SMALL-CELL LUNG CANCER (NSCLC);

RADIOTHERAPY;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DISEASE COURSE; DYSPHAGIA; DYSPNEA; ESOPHAGITIS; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEMOPTYSIS; HOARSENESS; HUMAN; LUNG DISEASE; LUNG NON SMALL CELL CANCER; MALE; MEASUREMENT; NAUSEA; PALLIATIVE THERAPY; PERFORMANCE; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; SPINAL CORD DISEASE; SYMPTOM; THORAX PAIN; TOXICITY; UNITED STATES;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; PROSPECTIVE STUDIES; UNITED STATES;

EID: 1542376216     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.08.005     Document Type: Article

References (27)

1. American Cancer Society. Cancer facts and figures - 2003. 2003;American Cancer Society, Atlanta.
2. Breathnach O.S., Freidlin B., Johnson B.E., et al. Twenty-two years of phase III trials for patients with non-small cell lung cancer Sobering results. J Clin Oncol. 19:2001;1734-1742.
3. Ginsberg R.J., Vokes E.E., Rosenzweig K. Non-small cell lung cancer: Epidemiology. DeVita V.T. Principles and practice of oncology. 6th ed :2001;941-959 Lippincott Williams & Wilkins, Philadelphia.
4. Baldini E.H. Palliative radiation therapy for non-small cell lung cancer. Hematol Oncol Clin North Am. 11:1997;303-319.
5. Simpson J.R., Francis M.E., Rao D.V., et al. Palliative radiotherapy for inoperable carcinoma of the lung Final report of a RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys. 11:1985;751-758.
6. Salazar O.M., Slawson R.G., Strohl R.A., et al. A prospective randomized trial comparing once-a-week vs daily radiation therapy for locally advanced, non-metastatic, lung cancer A preliminary report. Int J Radiat Oncol Biol Phys. 12:1986;779-787.
7. Teo P., Tai T.H., Choy D., et al. A randomized study on palliative radiation therapy for inoperable non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys. 14:1988;867-871.
8. Medical Research Council. Inoperable non-small cell lung cancer (NSCLC) A Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party. Br J Cancer. 63:1991;265-270.
9. Medical Research Council. A Medical Research Council randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small cell lung cancer and poor performance status. Br J Cancer. 65:1992;934-941.
10. Macbeth F.R., Bolger J.J., Bailey A.J., et al. Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Clin Oncol (R Coll Radiol). 8:1996;167-175.
11. Collins T.M., Ash D.V., Thorogood J., et al. An evaluation of the palliative role of radiotherapy in inoperable carcinoma of the bronchus. Clin Radiol. 39:1988;284-286.
12. Slotman B.J., Njo K.H., Karim A.B., et al. Hypofractionated radiation therapy in unresectable stage III non-small cell lung cancer. Cancer. 72:1993;1885-1893.
13. Appold S., Baumann M., Herrmann T., et al. Results of irradiation of inoperable stage III non-small cell lung cancer with 25Gy in five fractions. Strahlenther Onkol. 175:1999;267-270.
14. Stevens M.J., Begbie S.D. Hypofractionated irradiation for inoperable non-small cell lung cancer. Australas Radiol. 39:1995;265-270.
15. Rees G.J., Devrell C.E., Newman H.F., et al. Palliative radiotherapy for lung cancer Two versus five fractions. Clin Oncol (R Coll Radiol). 9:1997;90-95.
16. Vyas R.K., Suryanarayana U., Baboo H.A., et al. Inoperable non-small cell lung cancer Palliative radiotherapy with two weekly fractions. Indian J Chest Dis Allied Sci. 40:1998;171-174.
17. Lupattelli M., Maranzano E., Latini P., et al. Short-course palliative radiotherapy in non-small cell lung cancer Results of a prospective study. Am J Clin Oncol. 23:2000;89-93.
18. Plataniotis G.A., Kouvaris J.R., Vlahos L., et al. A short radiotherapy course for locally advanced non-small cell lung cancer (NSCLC) Effective palliation and patients' convenience. Lung Cancer. 35:2002;203-207.
19. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 5:1982;649-655.
20. Arbuck SG, Ivy SP, Setser A, et al. The Common Toxicity Criteria - Version 1, 1994, update 1998. http://ctep.info.nih.gov.
21. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
22. Hassey K.M., Rose C.M. Altered skin integrity in patients receiving radiation therapy. Oncol Nurs Forum. 9:1982;44-50.
23. Hilderley L. Skin care in radiation therapy A review of the literature. Oncol Nurs Forum. 10:1983;51-56.
24. Sheline G.E., Wara W.M., Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys. 6:1980;1215-1228.
25. Enami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic radiation. Int J Radiat Oncol Biol Phys. 21:1991;109-122.
26. Macbeth FR, Wheldon TD, Reed NS, et al., for the Medical Research Council Lung Cancer Working Party. Radiation myelopathy estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer. Clin Oncol (R Coll Radiol) 1996;8:176-181.
27. Dutreix J., Wambersie A., Bounik C. Cellular recovery in human skin reactions Application to dose fraction number overall time relationship in radiotherapy. Eur J Cancer. 9:1973;159-167.